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Background: The six-minute walking distance (6MWD) test has demonstrated validity and 
reliability to assess changes in functional capacity following pulmonary rehabilitation in patients 
with chronic obstructive lung disease. However, no attempt has been made to establish an itera-
tive measurement of 6MWD during the overall period of pulmonary rehabilitation. Therefore, 
the aim of this study was to evaluate the impact of a twelve-week rehabilitation program on the 
iterative weekly measurement of 6MWD in chronic obstructive pulmonary disease (COPD) 
patients and healthy subjects.
Methods: Twenty-six patients with COPD and nine age-matched healthy subjects were studied. 
Measurements were taken at baseline and after twelve weeks except for the 6MWD. The exercise 
measurements included a six-minute walking test (6MWT) and an incremental exercise test. 
Oxygen saturation, heart rate, and dyspnea will be monitored during all these tests.
Results: At baseline there were significant differences between groups, except in age, body 
mass index, and oxygen saturation. After 12 weeks, there was no significant change in lung 
function in patients with COPD and healthy subjects. The 6MWD, peak oxygen uptake V
.
O2peak 
and anaerobic threshold increased significantly after training in both groups (P , 0.01). The 
averaged trace of the 6MWD of patients with COPD and healthy subjects was followed-up 
respectively by a logarithmic and linear fitting. 6MWD showed a plateau after eight weeks in 
patients with COPD, however, it increased continually overall in healthy subjects.
Conclusion: Both patients with COPD and healthy subjects demonstrated functional responses 
to training but with somewhat different patterns in quality of the improvement of the 6MWD.
Keywords: six-minute walking distance (6MWD), chronic obstructive pulmonary disease 
(COPD), healthy subjects, pulmonary rehabilitation
Chronic obstructive pulmonary disease (COPD), characterized by chronic inflammation 
with irreversible airflow limitation, causes chronic morbidity and disability. COPD is 
predicted to be the fifth most frequent cause of death in the world.1 Dyspnea, decrease 
of exercise capacity, and impairment of quality of life are common in patients with 
COPD.2 Recently, it has been demonstrated that the decrease in exercise capacity is 
associated with mortality of these patients.1,2 Patients with COPD often report walking 
slower than people of the same age, having to stop walking to breathe, or not leaving 
the house because of breathlessness.3
Pulmonary rehabilitation is strongly endorsed as an evidence-based intervention 
for the management of patients with COPD.2 It is the recommended standard of care 
for patients with COPD as it has been shown to decrease the perception of dyspnea,4 to 
enhance exercise capacity,5 to reduce health care resource utilization5,6 and to improve 
health status.4 Reduction of lactic acidosis,7 reduction in   minute ventilation and heart International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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rate for a given work rate and enhanced activity of mitochon-
drial enzymes and improved capillary density in the trained 
muscles,8,9 are among the underlying physiological changes 
that contribute to these improvements.
Timed walking tests such as the six-minute walking test 
(6MWT) have gained popularity for use in clinical practice 
and research setting10–12 to assess changes in functional 
capacity following pulmonary rehabilitation intervention.11 
Previous studies using the 6MWT were conducted in patients 
with COPD, but did not include healthy subjects.13,14
The aim of this study was to evaluate the impact of a 
twelve-week rehabilitation program on the iterative mea-
surement of six-minute walking distance (6MWD) in COPD 
patients and healthy subjects.
Methods
study subject
The study has been approved by the Ethical Committee of the 
University Hospital of Sousse. Thirty-two patients from 
the department of physiology of the Academic Hospital of 
Sousse, Tunisia, who had been diagnosed with moderate to 
severe COPD and twelve healthy subjects, were included in 
the study after giving their informed consent to participate. 
Diagnosis of COPD was made according to international 
recommendations.1 At the start of the study, patients were 
clinically stable; they received regular treatment with inhaled 
bronchodilators and inhaled steroids according to current 
guideline for their disease stage. Patients with a significant 
response following bronchodilator use, defined as an increase 
in forced expiratory volume in one second (FEV1) of more 
than 12% and 200 mL, patients with congestive heart failure, 
ischemic heart disease, or neuromuscular problems; and 
patients who had participated in an earlier training program, 
were excluded from the study.
The healthy subjects were all nonsmokers and free of 
significant cardiovascular, metabolic, and musculoskeletal 
disorders that could limit exercise capacity.
study design
Subjects were evaluated on three consecutive days at baseline 
and at the end of the three months training program. On the 
first day of the study, patients were informed of the purpose 
of the study and had agreed to participate. Pulmonary func-
tion test was performed using a body plethysmograph. On 
the second day a 6MWT test was performed. On the third 
day, the exercise capacity was assessed by using a cycle   
ergometer.
Methods
Pulmonary function test
All participants underwent spirometry with determination 
of FEV1 and forced vital capacity (FVC). Spirometry was 
performed using the pneumotachograph of a constant vol-
ume plethysmograph (ZAN 500 Body II; ZAN Meßgreräte 
GmbH, Germany) according to European Respiratory Soci-
ety recommendations.15
exercise testing
Subjects were evaluated before and after rehabilitation pro-
gram. An exercise test was performed on a calibrated cycle 
ergometer (Ergoline, Bitz, Germany) according to the individu-
alized and standardized exercise test protocol reported by the 
American Thoracic Society and American College of Chest 
Physicians.16 The maximal predicted work load was calculated 
and adapted to the patient by multiplication of the percentage 
fall in FEV1 by comparison to the predicted value.
Prior to each experiment, the volume and the gas analy-
sers were calibrated. The theoretical maximal oxygen uptake 
(V
.
O2max Th) was calculated.16 Subject wore a mask for gas 
exchange analysis using a breath-by-breath automated exer-
cise metabolic system (ZAN 600 Ergotest; ZAN Meßgeräte 
GmbH). The three-minute warm-up was conducted at 20% 
of this maximal estimated workload. The workload was then 
increased every minute. The rate of increase was defined as 
8% of maximal estimated workload, in order to obtain the 
maximal workload in about 10 minutes.
Oxygen saturation (SO2) was continuously monitored 
via a finger pulse oxymeter (Model 9847 Nonin Medical, 
Inc.; Minneapolis, MN, USA). Systolic blood pressure and 
dyspnea (Borg CR-10 scale) were recorded before and after 
exercise. The heart rate was continuously monitored using a 
12-lead ECG (ZAN ECG, 800; ZAN Meßgeräte GmbH).
To ensure that peak oxygen uptake (V
.
O2peak) was attained, at 
least three of the following criteria had to be met: an increase 
in V
.
O2 , 5 mL with the last increase in work rate; attainment 
of age predicted maximal cardiac frequency; a respiratory 
exchange ratio .1.10 and an inability to maintain the required 
pedaling frequency (60 rev min−1) despite maximal effort and 
verbal encouragement. V
.
O2peak was accepted as maximum V
.
O2. 
The anaerobic threshold was determined by the V-slope 
method and confirmed by the traditional gas exchange.17
six-minute walking test
The 6MWT was performed before and every week during 
the three months of the rehabilitation program. The 6MWT International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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was conducted according to international recommendations.10 
Reference values were calculated by Tunisian equations.18 
Subjects were instructed to walk at their own maximal pace 
along a 40 m long hospital corridor. They were asked to cover 
as much distance as they could within six minutes. Subjects 
were given feedback on time progression at each minute. 
Subjects were allowed to stop and rest during the test, but 
were instructed to resume walking as soon as they felt able 
to do so. Before the test, patients rested in a chair, located 
near the starting position, for $10 minutes. Heart rate and 
SO2 were measured for one minute at baseline, and during 
the first minute of recovery by a pulse oxymeter. Pre- and 
post-walk dyspnea was recorded using the Borg scale. At 
the end of the 6MWT, the participant was told to stop, and 
ambulatory distance was recorded.
Training program
The subjects were required to participate in the rehabilita-
tion program three days/week during the three months. 
They received the same exercise training and education 
program. This consisted of two sessions of 30 minutes/week 
of seminars and discussions covering the following topics: 
relaxation, disease education, benefits advice, energy con-
versation, medication advice, chest clearance, and breathing 
control techniques. The training schedule was the same in the 
two groups, consisting of a five minute warm-up followed 
by 10 minutes of work and five minutes of active recovery, 
repeated over a 45 minute session. The exercise program 
was individualized according to the initial physical fitness 
assessment before intervention. Each subject was trained 
to its target heart rate corresponding to the gas exchange 
threshold. Subjects were instructed to perform a stationary 
bicycle exercise and the warm-up, cool-down, and upper 
extremity exercises. During training, heart rate was continu-
ously monitored by means of a cardiofrequency meter (Polar, 
S810). The cardiofrequency meter was set in such a way that 
subject could exercise within ± 5 beats/minute of prescribed 
intensity. An alarm insured that the subject trained within the 
preselected range.
Analysis
The results of the study are presented as mean ± standard 
deviation (SD). The nonparametric Mann–Whitney U test 
was used to compare baseline characteristics and training-
related changes in patients with COPD and healthy subjects, 
Wilcoxon’s matched pairs test was used to assess training-
induced changes within the group. Repeated measures 
ANOVA was used to assess weekly changes of 6MWD overall 
of pulmonary rehabilitation. When the ANOVA F ratio was 
significant, the means were compared by using the post-hoc 
contrast test. The statistical program Statistica was used for 
the analysis (Statistica Kernel Version 6; Stat Soft, France). 
The level of significance was set as P , 0.05.
Results
Six patients and three healthy subjects were dropped out 
of the rehabilitation group due to an acute exacerbation of 
respiratory symptoms and lack of motivation or transport 
problems.
Anthropometric characteristics and pulmonary function 
parameters of patients with COPD and healthy subjects 
before and after the rehabilitation program are provided in 
Table 1. Age and body mass index (BMI) were similar in both 
groups. The main differences were observed in pulmonary 
function where the patients with COPD showed moderate 
to very severe airflow obstruction. There was no significant 
change in FEV1 and FVC in the two groups after rehabilita-
tion program.
Table 2 shows exercise characteristics of patients with 
COPD and healthy subjects before and after the rehabilita-
tion program. There are significant changes in V
.
O2peak, the 
anaerobic threshold, dyspnea, and heart rate (P , 0.01). The 
SO2 did not change significantly after rehabilitation program 
in both groups.
The 6MWD increased significantly after the rehabilita-
tion program in both groups (P , 0.01), as shown in Table 3. 
The dyspnea and heart rate at the peak of 6MWT decreased 
significantly after the rehabilitation program (P , 0.05). 
Any change in SO2% was marked at the peak of 6MWT 
in both groups compared with values before rehabilitation 
program.
Figure 1 shows the averaged trace and the corresponding 
logarithmic and linear fitting of the dependant variables of 
6MWD for patients with COPD and healthy subjects.
The average walking distance of both groups increased 
significantly during the first week of training (P , 0.05), 
and within two weeks all the subjects showed an increase 
in 6MWD. The mean walking distance in COPD patients 
increased according to a logarithmic curve (r = 0.98). The 
walking distance in healthy subjects increased linearly 
during the overall period of training (r = 0.98). However, 
in patients with COPD, it continued to improve and reach-
ing 613.91 ± 56.06 m after eight weeks, after that the mean 
distance showed little change which presented as a plateau. International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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Table 1 Anthropometric characteristics and pulmonary function parameters of healthy subjects and patients with chronic obstructive 
pulmonary disease before and after rehabilitation program
Healthy subjects (n = 9) Patients with COPD (n = 26)
Before RP After RP Before RP After RP
Age, Yr 58 ± 7 – 61 ± 4 –
BMI; kg/m2 26,52 ± 1.78 25.19 ± 2.13 24.01 ± 5.16 25.18 ± 4.61
FeV1, L 2.94 ± 0.45 2.97 ± 0.56 1.42 ± 0.52*** 1.57 ± 0.75†††
FeV1, % Predicted 88.66 ± 9.1 92.50 ± 5.17 48.86 ± 11.31*** 51.31 ± 9.73†††
FVC, L 3.16 ± 0.57 3.27 ± 0.51 2.21 ± 0.86*** 2.36 ± 0.71†††
FVC, % Predicted 82.75 ± 13.29 85.49 ± 9.41 58.82 ± 9.8*** 65.43 ± 7.42†††
FeV1/FVC ratio 82.81 ± 9.5 84.27 ± 10.75 55.64 ± 8.91*** 57.91 ± 9.91†††
Unit: Mean ± sD; n, number of subjects. 
Notes: Comparisons between patients with COPD and healthy subjects before rehabilitation program: ***P , 0.001; Comparisons between patients with COPD and healthy 
subjects after rehabilitation program: †††P , 0.001.
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass index; FeV1, forced expiratory volume in one second; FVC, forced vital capacity; RP, 
rehabilitation program. 
Table 2 exercise characteristics of healthy subjects and patients with chronic obstructive pulmonary disease before and after 
rehabilitation program
Healthy subjects (n = 9) Patients with COPD (n = 26)
Before RP After RP Before RP After RP
V
.
O2peak, mL min−1 Kg−1 29.03 ± 6.15 32.6 ± 4.32** 26,27 ± 3.23‡‡ 27.54 ± 5.7†† §§§
Anaerobic threshold, l min−1 1.18 ± 0.22 1.38 ± 0.24** 0.84 ± 0.09‡‡‡ 1.12 ± 0.05†† §§
Dyspnea
  Rest 0.2 ± 0.3 0.14 ± 0.23 2.4 ± 1.7‡‡‡ 1.4 ± 0.6†††
  Peak 3.45 ± 1.12 1.02 ± 1.18** 6.6 ± 1.9‡‡‡ 3.3 ± 2.7†††
sO2, %
  Rest 96.2 ± 0.2 96 ± 1.3 94 ± 1.24‡‡ 93 ± 2.5§§
  Peak 95 ± 1.8 96.21 ± 1.5 91 ± 3‡‡‡ 92.27 ± 1.3§§§
hR, bat min−1 156.72 ± 18.9 149.27 ± 18.4** 136 ± 7‡‡‡ 137 ± 5††
Unit: mean ± sD; V
.
O2peakl/min. 
Notes: Comparison in healthy subjects with values before and after rehabilitation program: **P # 0.01; Comparison in patients with COPD with values before and after 
rehabilitation program: ††P # 0.01, †††P # 0.001; Comparison between patients with COPD and healthy subjects before rehabilitation program: ‡‡P # 0.01, ‡‡‡P # 0.001; 
Comparison between patients with COPD and healthy subjects after rehabilitation program: §§P # 0.01, §§§P # 0.01.
Abbreviations: hR, heart rate; sO2, oxygen saturation; VO2peak, peak oxygen uptake; COPD, chronic obstructive pulmonary disease; RP, rehabilitation program. 
Table 3 six-minute walking test parameters of healthy subjects and patients with chronic obstructive pulmonary disease before and 
after rehabilitation program
Healthy subjects (n = 9) Patients with COPD (n = 26)
Before RP After RP Before RP After RP
6MWD, m 600 ± 28.28 789 ± 19.07** 504 ± 55.46‡‡‡ 620 ± 69.71††,§§§
6MWD, % 86 ± 4 113 ± 3** 72 ± 8‡‡‡ 89 ± 10††,§§§
sO2, %
  Rest 96.9 ± 1.13 96.72 ± 1.1 96 ± 2.4 95 ± 2.7
  Peak 96.27 ± 1.1 95.45 ± 1.8 91.82 ± 4.5‡‡‡ 89 ± 6.5§§§
Dyspnea
  Rest 0.18 ± 0.4 0.91 ± 0.3* 0.72 ± 1.27‡‡ 0.45 ± 0.47†,§§
  Peak 1.72 ± 1.48 0.36 ± 0.5* 4.5 ± 3.033‡‡‡ 2.59 ± 2.13† §
hR
  Rest 73.72 ± 8.9 65 ± 4.07 75.63 ± 13.87‡‡ 76.45 ± 14.03§§
  Peak 87.8 ± 12.1 82.27 ± 27.7* 111.09 ± 11.2‡‡ 104.81 ± 22.7†,§§§
Unit: Mean ± sD. 
Notes: Comparison in healthy subjects with values before and after rehabilitation program, *P # 0.05, **P # 0.01; Comparison in patients with COPD with values before 
and after rehabilitation program, †P # 0.05, ††P # 0.01; Comparison between patients with COPD and healthy subjects before rehabilitation program; ‡‡P # 0.01, ‡‡‡P # 0.001; 
Comparison between patients with COPD and healthy subjects after rehabilitation program, §P # 0.05, §§P # 0.01, §§§P # 0.001.
Abbreviations: 6MWD, six-minute walking distance; hR, heart rate; sO2, oxygen saturation; RP, rehabilitation program. International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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On the last evaluation, the mean walking distance was 
620.73 ± 69.71 m. However, the walking distance of healthy 
subjects increased continually overall period of the rehabili-
tation program.
Discussion
The aim of this study was to evaluate the impact of 12 weeks, 
rehabilitation program on the iterative measurement of 
6MWD in COPD patients and healthy subjects.
The major finding of this study was that, for comparable 
training conditions and duration, while patients with COPD 
and healthy subjects presented a distinct 6MWD response 
during endurance training, these responses differed quanti-
tatively and qualitatively.
Quantitatively, the increase of 6MWD was significantly 
higher in controls than patients with COPD. From a quali-
tative point of view, physical training induces, in COPD 
patients, a logarithmic increase of 6MWD. Whereas, healthy 
controls showed a linear increase in the same period of 
training.
Assessment of cardiopulmonary function and V
.
O2peak 
during exercise stress reveals valuable insights with respect 
to the disease process and limitations imposed.17 Exercise 
training programs were individualized. They were adapted 
to the individual limitations of the patient, taking cardio-
vascular, pulmonary, and skeletal muscle limitations into 
account and can be demonstrated to show overall benefit for 
each patient.19
As demonstrated in other studies,7 no significant modi-
fication of pulmonary function was marked after a training 
program. Indeed, respiratory muscles are affected by multiple 
factors related to both the presence and severity of COPD 
which may impair their structure and function.20 Pulmonary 
rehabilitation causes modification in peripheral myopathy 
but not ventilator limitation. The airflow limitation in most 
cases is both progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles or 
gases.19
The effect of individualized training on dyspnea peak and 
the maximal heart rate after 6MWT and exercise test, after 
rehabilitation program, was significantly important in both 
groups. This could be explained, firstly by improved physi-
cal conditions and a very good response to exercise, which 
supports a decreased sensation of dyspnea.21 Secondly, by 
some physiological changes, like better cardiac adaptation, 
decrease in lactic acid production and reduction in metabolic 
cost of exercise.7 This also explains the significant improve-
ment of V
.
O2peak (13%) for patients with COPD. This result was 
similar to some studies which showed 10% improvement of 
V
.
O2peak
20 and differs from other studies which showed 20% 
improvement.22 This difference could be due to the varia-
tion in the length of training periods or to the intensity of 
training.
Compared to the healthy controls, COPD patients had 
significantly less walking distance during 6MWT. The 
magnitude of the overall increase in walking distance is in 
agreement with previous findings.23 In our study, patients 
showed a mean increase in the 6MWT of 117 m or 23% 
in COPD patients and of 189 m in healthy subjects or 32% 
after 12 weeks. The percentage of walking distance improve-
ment in patients with COPD was similar to those reported 
by Troosters et al.24 In this study, patients with moderate to 
severe COPD, who tolerate exercise, presented an increase 
of 25% in their 6MWD.
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Quantitatively, the largest difference in 6MWD between 
COPD patients and healthy subjects can be explained by the 
more fatigability of the quadriceps in patients with COPD 
than in healthy subject. Indeed, as shown in another study,25 
which compared patients with COPD to normal subjects, 
peripheral muscle strength was not completely corrected after 
training in COPD patients,26,27 suggesting that factors others 
than chronic inactivity are involved in explaining muscle 
atrophy and weakness in patients with COPD.22 In young 
and older normal subjects, muscle hypertrophy and improved 
neural recruitment patterns account for the increase in muscle 
strength following program training.24,28 Both mechanisms 
could play an important role in the improvement of walking 
distance after training the participants.
Qualitatively, the progress of 6MWD presented a linear 
and a logarithmic improvement respectively for patients with 
COPD and healthy subjects during program training. The 
above linear increase could be explained by a linear rise of 
V
.
O2peak after program training.28,29 In contrast, COPD patients 
reached a plateau after eight weeks which may be due to many 
factors such as baseline structure and biochemical status in 
COPD muscles6,8 or oxidative stress induced by exercise.23 
Evidence show that the exercise intolerance in patients with 
COPD is related to muscular dysfunction, that includes low 
muscle mass and strength,5 low muscle aerobic enzymes 
and capillarity,6 early onset of lactic acidosis,7 among other 
effects.24
Oxidative stress have also been suggested as a potential 
mechanism in the pathogenesis of COPD and can explain a 
plateau observed after eight weeks in patients with COPD.30 
Evidence for increased oxidative stress in obstructive airway 
diseases is emerging and several studies have suggested 
that it can play an important role in their evolution and 
pathogenesis.23
Opposed to the benefits of the physical exercise on 
patient with COPD, evidences indicate that physical exercise, 
especially aerobic, generate reactive oxygen species such as 
superoxide anion and hydrogen peroxide, capable of causing 
muscular damage and inflammation.30 This process is known 
as oxidative damage and could limit the 6MWD progress in 
patients with COPD.31
These qualitative changes could also be explained by the 
effect of training on muscle gene expression in COPD and 
healthy subjects. Indeed, different patterns in muscle gene 
expression were described, potentially reflecting the specific 
molecular response of the muscle to exercise in patients with 
COPD and suggesting additional mechanisms for exercise 
limitation in COPD.24
In conclusion, the findings of this study demonstrate 
that an individualized training is more likely to produce 
optimal benefit for patients with COPD like healthy 
subjects but with some differences. Rehabilitation program, 
over 12 weeks, induces a linear improvement of 6MWD 
in healthy subjects, and a logarithmic improvement for 
patients with COPD.
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